{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:24:17Z","timestamp":1791404657117,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jsbmb.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T11:31:34Z","timestamp":1402313494000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"special_numbering":"C","title":["All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause"],"prefix":"10.1016","volume":"145","author":[{"given":"Fernand","family":"Labrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2014.06.001_bib0005","first-page":"159","article-title":"Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data","volume":"52","author":"Archer","year":"2007","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13697130701543783","article-title":"The heart of the WHI study: time for hormone therapy policies to be revised","volume":"10","author":"Pines","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0020","series-title":"WHO technical report series No 866","article-title":"Research on the menopause in the 1990s","author":"W.H.O. Scientific Group","year":"1996"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ncpendmet0559","article-title":"Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy","volume":"3","author":"Labrie","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpobgyn.2008.10.008","article-title":"Management of premature ovarian failure","volume":"23","author":"Panay","year":"2009","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0035","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","article-title":"Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healty postmenopausal women","volume":"90","author":"Simon","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0040","series-title":"Menopause Practice: A Clinician\u2019s Guide","first-page":"9","article-title":"Overview of menopause and aging","author":"NAMS: Professional Education Committee","year":"2007"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/JOM.0b013e3182820515","article-title":"Direct and indirect costs of women diagnosed with menopause symptoms","volume":"55","author":"Kleinman","year":"2013","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/aje\/152.5.463","article-title":"Relation of demographic and lifestyle factors to symptoms in a multi-racial\/ethnic population of women 40\u201355 years of age","volume":"152","author":"Gold","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9378(87)90298-5","article-title":"Characteristics of menopausal women seeking assistance","volume":"156","author":"Anderson","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2008.12.006","article-title":"Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life","volume":"62","author":"Williams","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e3181e195a6","article-title":"Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?","volume":"18","author":"Labrie","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/endo-123-3-1412","article-title":"Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate","volume":"123","author":"Labrie","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0075","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0080","first-page":"14","article-title":"DHEA after menopause\u2013sole source of sex steroids and potential sex steroid deficiency treatment","volume":"19","author":"Labrie","year":"2010","journal-title":"Menopause Management"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0085","series-title":"Important Advances in Oncology","first-page":"193","article-title":"Complete androgen blockade for the treatment of prostate cancer","author":"Labrie","year":"1985"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06264","article-title":"Is DHEA a hormone? Starling review","volume":"187","author":"Labrie","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0095","first-page":"161","article-title":"Assessment of steroidogenic pathways that do not require testosterone as intermediate","volume":"5","author":"Luu-The","year":"2011","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0100","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/endo-124-6-2745","article-title":"Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate","volume":"124","author":"Labrie","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0960-0760(92)90308-6","article-title":"Structure, function and tissue-specific gene expression of 3\u00e9-hydroxysteroid dehydrogenase\/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues","volume":"43","author":"Labrie","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/endo.131.3.1505484","article-title":"Structure of human type II 5 alpha-reductase gene","volume":"131","author":"Labrie","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/dna.1995.14.849","article-title":"The human type II 17\u03b2-hydroxysteroid dehydrogenase gene encodes two alternatively-spliced messenger RNA species","volume":"14","author":"Labrie","year":"1995","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0960-0760(95)00209-X","article-title":"Characteristics of human types 1, 2 and 3 17b-hydroxysteroid dehydrogenase activities: oxidation-reduction and inhibition","volume":"55","author":"Luu-The","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0125","doi-asserted-by":"crossref","unstructured":"Labrie F, Simard J, Luu-The V, B\u00e9langer A, Pelletier G, Morel Y, et al., The 3\u03b2-hydroxysteroid dehydrogenase\/isomerase gene family: lessons from type II 3\u03b2-HSD congenital deficiency. Signal Transduction in Testicular Cells, Ernst Schering Research Foundation Workshop. 1996; Suppl. 2:185-218.","DOI":"10.1007\/978-3-662-03230-5_10"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0039-128X(96)00174-2","article-title":"The key role of 17\u03b2-HSDs in sex steroid biology","volume":"62","author":"Labrie","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-4731(81)90140-0","article-title":"Inability of human endometrium or myometrium to aromatize androstenedione","volume":"14","author":"Baxendale","year":"1981","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","article-title":"Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment","volume":"57","author":"Bulun","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0145","first-page":"210","article-title":"Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues","volume":"8","author":"Toda","year":"1994","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0150","series-title":"Design and Application of Prodrugs (In a Texbook of Drug Design and Development)","author":"Bundgaard","year":"1991"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humrep\/dei373","article-title":"The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression","volume":"21","author":"Havelock","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2003.11.007","article-title":"Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors","volume":"215","author":"Baker","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/13697137.2012.733983","article-title":"DHEA and intracrinology at menopause, a positive choice for evolution of the human species","volume":"16","author":"Labrie","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Ster. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0175","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9378(79)90289-8","article-title":"Effects of long-term estrogen replacement therapy. II. Neoplasia","volume":"133","author":"Hammond","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0180","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","article-title":"Association of exogenous estrogen and endometrial carcinoma","volume":"293","author":"Smith","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen\/progestin interventions (PEPI) trial. The writing group for the PEPI trial","volume":"275","author":"The Writing Group for the Trial","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5122(86)90025-3","article-title":"Steroid and gonadotropin levels in women during the peri-menopausal years","volume":"8","author":"Longcope","year":"1986","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0195","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulfate and sex hormone binding globulin levels through the menopause transition","volume":"85","author":"Burger","year":"2000","journal-title":"J. Clin. Endocrin. Metab."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(94)00869-9","article-title":"A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density","volume":"21","author":"Rannevik","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/gme.0b013e31819e8e2d","article-title":"Intravaginal dehydroepiandrosterone (prasterone), a physiological and highly efficient treatment of vaginal atrophy","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/gme.0b013e31819e85c6","article-title":"Effect on intravaginal dehydroepiandrosterone (prasterone) on libido and sexual dysfunction in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/en.2005-0870","article-title":"Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity","volume":"147","author":"Pessina","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0220","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/jsm.12219","article-title":"Androgenic action of dehydroepiandrosterone (DHEA) on nerve density in the ovariectomized rat vagina","volume":"10","author":"Pelletier","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0225","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/gme.0b013e31819e8930","article-title":"Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"111","author":"Labrie","year":"2008","journal-title":"J. Ster. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsbmb.2008.09.007","article-title":"Corrigendum to: effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"112","author":"Labrie","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jsbmb.2013.08.002","article-title":"Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens","volume":"138","author":"Labrie","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2010.483297","article-title":"Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets","volume":"13","author":"Eugster-Hausmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2014.06.001_bib0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:48:25Z","timestamp":1760744905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076014001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":50,"alternative-id":["S0960076014001150"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.001","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}